09:00 Feng XU，Chief IP Consultant and the Assistant Vice President of China & Asia Region, AstraZeneca 09:35 Wenyi PENG，Former Judge, Beijing Intellectual Property Court; Arbitrator of the Beijing Arbitration Commission, and Mediator of the Beijing Sunshine Intellectual Property Mediation Center 10:10 Xiaoping HE，Assistant Vice President and IP Head for Asia Region, Eli Lilly 10:45 Coffee Break 11:15 Wenjun GENG，Vice President, CTTQ PHARMA 11:50 Moderator: Rongxia WANG，Deputy Legal Director, AstraZeneca Tina TAI，Co-Head of Patent, King & Wood Mallesons Wenqiang ZHOU，Senior Patent Manager, Roche Changgang LOU，Head of IP, Takeda (China) Liming SUN，Senior IP Director, Qilu Pharmaceutical 12:40 Lunch 14:00 Wei CHEN，Former Director of Reexamination and Invalidation Department, CNIPA 14:35 Richard T. Ruzich，Partner, Taft Stettinius & Hollister Ian Scott，Partner, Taft Stettinius & Hollister 15:10 15:45 Tea Break 16:15 Lifang SUN，Vice President of Intellectual Property Department, Luye Pharma Group 16:50 Moderator: Huadong TANG，Partner, Merits & Tree Law Offices Tommy LIN，Vice President, Board Secretary and Director of IP and BD, HEC Pharma Ming WU，VP for Business Development Dept.,TYK Medicines Xiaojun LIAO，Senior IP Director, Legend Biotech Daisy WU，Executive Director and Head of IP, Shanghai Henlius Biotech Co., Ltd. 18:00 Round Table Dinner Development Trends of Pharmaceutical Intellectual Property Protection and Impact on the Industry Differences, Similarities, and Considerations of Pharmaceutical Patent Linkage Systems in Asia-Pacific Countries Round Table: IP Management of Chinese Innovative Drugs License-out Updates on Patent Term Extension in China Key Issues and Adjudication Thoughts in Patent Linkage Disputes Round Table: Drug Application and Market Entry Strategies under the Patent Term Extension System Case Analysis of Pharmaceutical Patent Invalidation in China Invalidity Strategies in the US for Chinese Pharmaceutical Companies Practical Approaches and Case Analysis for Handling Overseas Intellectual Property Disputes EPO Updates on Patent Protection in Pharmaceutical Field 09:00 Wuzong ZENG，Level ⅠExaminer, CNIPA 09:35 10:10 10:45 Tea Break 11:10 Lu HUANG，Master Supervisor & Senior Engineer, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology 11:45 Qian MA，Biological Drug IP Director, Simcere Pharmaceutical 12:30 Closing of Sub-forum A & Lunch Dynamics of Invention Patent Examination for Pharmaceutical in China Global IP Portfolio Strategy for Domestic Pharmaceutical Companies Global Layout Strategy of Indications Patents Global Patent Layout Strategies of Multinational Pharmaceutical Companies Topic to Be Determined |
IP Link is a subsidiary platform under Infotrans. With the mission of "enhancing IP management and utilization, promoting industry innovation and development" , IP Link aims to become the premier learning and networking platform in the intellectual property field by organizing various activities and connecting IP practitioners.
IP Link Events Include:
1. Intellectual Property Industry Forum and IP Link Partnering (held annually);
2. IP Link Practical Forum (several sessions per year);
3. IP Link Online Courses;
4. IP Link Seminars;
5. Other events;
Contact: Raven LIN, Mobile: 0086-18259157913
About IP Link
Scan the QR Code to Register:
